PK
Pritam Kumar Gupta
About Pritam Kumar Gupta
Data last updated:
Pritam Kumar Gupta is a Director at Orfit Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma and Chemicals. Earlier, Pritam Kumar Gupta was a Director at Nero Pharmaceuticals Private Limited (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orfit Pharmaceuticals Private Limited U46497DL2024PTC438434 | Director | 06 Nov 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nero Pharmaceuticals Private Limited U24290DL2022PTC396508 | Director | 11 Apr 2022 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pritam Kumar Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anu Sinha | 11040464 | Orfit Pharmaceuticals Private Limited | Director |
| Deepak Kumar | 11040457 | Orfit Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pritam Kumar Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pritam Kumar Gupta
Pritam Kumar Gupta currently holds 1 directorship: Orfit Pharmaceuticals Private Limited (Director, since 06 Nov 2024).
Pritam Kumar Gupta was first appointed on 11 Apr 2022 as Director at Nero Pharmaceuticals Private Limited. The most recent appointment on record is 06 Nov 2024 at Orfit Pharmaceuticals Private Limited.
Pritam Kumar Gupta held 1 earlier board appointment: Nero Pharmaceuticals Private Limited (Director, 11 Apr 2022 to 02 May 2025).
The current boards of Pritam Kumar Gupta's companies include Anu Sinha (Orfit Pharmaceuticals Private Limited), Deepak Kumar (Orfit Pharmaceuticals Private Limited).